8-K Filing Summary: The Beauty Health Company (SKIN)

• Critical Event: Appointment of Dr. Philippe Schaison to the Board of Directors, effective October 30, 2025.
• Independence: Dr. Schaison qualifies as an independent director under Nasdaq and SEC rules.
• Strategic Value: He brings significant experience scaling global health and beauty franchises, having held leadership roles at Allergan Aesthetic, Syneron Candela, and Soltégo, Inc.
• Committee Roles: Appointed to both the Nominating and Corporate Governance Committee and the **Compensation Committe